<p>PC12 cells were pretreated with T6FA (2–50 µM) for 30 min, before exposure to Aβ<sub>1–40</sub> (20 µM) or the reverse peptide Aβ<sub>40–1</sub> or vehicle for additional 24 h. The cellular viability was evaluated by phase-contrast microscopy observation (A) and MTT assay (B). (A) Representative phase-contrast photographs of PC12 cells: a, control; b, Aβ<sub>1–40</sub>; c, T6FA and d, T6FA plus Aβ<sub>1–40</sub>. Scale bar = 50 µM. (B) The data were expressed as percentage of the control (non-treated cells). The control treatment is set to 100%. Bars are means ± S.E. We used ** P<0.01 and * P<0.05 versus control, ##P<0.01 versus Aβ<sub>1–40</sub> treatment (n = 6).</p
<p>(A) PC12 cells were stimulated with glutamate (1, 5, 10 mM) or vehicle control for 24 h and cell ...
<p>NIH3T3 cells were transduced with empty vector or retrovirus expressing CA-NFAT1 or CA-NFAT1 DD69...
<p>(A) 1205Lu melanoma cells were treated with the indicated siRNAs together with 1 µM 5-fluorouraci...
<p>Treatment of cells and measurement of oxidative stress levels using the DCF-DA assay were as desc...
<p>Panel (A) documents AIF-TRITC visualized by fluorescence microscope, magnification 600×, scale ba...
<p>(A), Sa3 cells were incubated with or without 5 mg/mL of 5-FU for 1 h and 3 h. The cells then sta...
<p>Cells were incubated with FA concentrations ranging from 0 to 500 μM for 48 h. Data are presented...
<p>(A) The schematic illustrates the amino acid sequence of each CPPP derivative. (B–C) MDA-MB 468 c...
<p>PC12 cells were incubated for 24 (A) and 96 h (B, C) in the presence of oligomeric Aβ (AβO, 1 μM)...
<p>NT2-A cells were treated with fA<i>β</i>, simvastatin ± A<i>β</i> (A), lovastatin ± A<i>β</i> (B)...
<p>Panel A shows kinetics of AIF release and panel B activity of PARP1 in PC3 cells exposed to α-TOS...
<p>(A) MCF7 cells were transfected with pcDNA3-βNAC and treated with siRNA oligos against <i>βNAC</i...
<p>(A) LNCaP cells were treated with 100 ng/ml NRG for 24 h with or without 20 µM SP600125. Whole ce...
<p><u>Cell viability assay</u>: (A) HeLa cells, or (B) other adherent cell lines, were incubated for...
<p>Cells were treated with different concentrations (5, 10, 20 μmol/L) of Aβ<sub>25–35</sub> for 24 ...
<p>(A) PC12 cells were stimulated with glutamate (1, 5, 10 mM) or vehicle control for 24 h and cell ...
<p>NIH3T3 cells were transduced with empty vector or retrovirus expressing CA-NFAT1 or CA-NFAT1 DD69...
<p>(A) 1205Lu melanoma cells were treated with the indicated siRNAs together with 1 µM 5-fluorouraci...
<p>Treatment of cells and measurement of oxidative stress levels using the DCF-DA assay were as desc...
<p>Panel (A) documents AIF-TRITC visualized by fluorescence microscope, magnification 600×, scale ba...
<p>(A), Sa3 cells were incubated with or without 5 mg/mL of 5-FU for 1 h and 3 h. The cells then sta...
<p>Cells were incubated with FA concentrations ranging from 0 to 500 μM for 48 h. Data are presented...
<p>(A) The schematic illustrates the amino acid sequence of each CPPP derivative. (B–C) MDA-MB 468 c...
<p>PC12 cells were incubated for 24 (A) and 96 h (B, C) in the presence of oligomeric Aβ (AβO, 1 μM)...
<p>NT2-A cells were treated with fA<i>β</i>, simvastatin ± A<i>β</i> (A), lovastatin ± A<i>β</i> (B)...
<p>Panel A shows kinetics of AIF release and panel B activity of PARP1 in PC3 cells exposed to α-TOS...
<p>(A) MCF7 cells were transfected with pcDNA3-βNAC and treated with siRNA oligos against <i>βNAC</i...
<p>(A) LNCaP cells were treated with 100 ng/ml NRG for 24 h with or without 20 µM SP600125. Whole ce...
<p><u>Cell viability assay</u>: (A) HeLa cells, or (B) other adherent cell lines, were incubated for...
<p>Cells were treated with different concentrations (5, 10, 20 μmol/L) of Aβ<sub>25–35</sub> for 24 ...
<p>(A) PC12 cells were stimulated with glutamate (1, 5, 10 mM) or vehicle control for 24 h and cell ...
<p>NIH3T3 cells were transduced with empty vector or retrovirus expressing CA-NFAT1 or CA-NFAT1 DD69...
<p>(A) 1205Lu melanoma cells were treated with the indicated siRNAs together with 1 µM 5-fluorouraci...